Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (31-40 of 270) with videos related to

Pageof 27
Sort By:
Biorxiv : the Preprint Server for Biology|September 15, 2025
Statistical Methods for Binary Outcomes Adjusting for Outcome Dependent Sampling in Longitudinal Studies with Nonignorable DropoutCarter J Sevick, Samantha MaWhinney, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2025
Recommendations for interpreting intraerythrocytic tenofovir-diphosphate and emtricitabine-triphosphate for PrEP adherence assessmentPeter L Anderson, Corwin Coppinger, Mackenzie L Cottrell, et al.
Biomedical Chromatography : BMC|April 6, 2011
Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasmaJoseph E Rower, Brandon Klein, Lane R Bushman, et al.
Pharmacotherapy|July 30, 2009
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjectsMarypeace McRae, Patrick G Clay, Peter L Anderson, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Effect of nucleoside and nucleotide analog reverse transcriptase inhibitors on cell-mediated immune functionsLaura Enomoto, Peter L Anderson, Shaobing Li, et al.
AIDS Research and Human Retroviruses|April 29, 2021
<i>Letter to the Editor:</i> Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, David V Glidden, Robert M Grant, et al.
Pharmacotherapy|March 24, 2006
Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infectionJennifer J Kiser, Kenneth A Lichtenstein, Peter L Anderson, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Review and management of drug interactions with boceprevir and telaprevirJennifer J Kiser, James R Burton, Peter L Anderson, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acidPeter L Anderson, Richard C Brundage, Thomas N Kakuda, et al.
Frontiers in Pharmacology|September 28, 2020
Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIVMax von Kleist, J Gerardo García-Lerma, Albert Liu, et al.
Pageof 27

Showing results (31-40 of 270) with videos related to

Sort By:
Pageof 27
Biorxiv : the Preprint Server for Biology|September 15, 2025
Statistical Methods for Binary Outcomes Adjusting for Outcome Dependent Sampling in Longitudinal Studies with Nonignorable DropoutCarter J Sevick, Samantha MaWhinney, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2025
Recommendations for interpreting intraerythrocytic tenofovir-diphosphate and emtricitabine-triphosphate for PrEP adherence assessmentPeter L Anderson, Corwin Coppinger, Mackenzie L Cottrell, et al.
Biomedical Chromatography : BMC|April 6, 2011
Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasmaJoseph E Rower, Brandon Klein, Lane R Bushman, et al.
Pharmacotherapy|July 30, 2009
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjectsMarypeace McRae, Patrick G Clay, Peter L Anderson, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Effect of nucleoside and nucleotide analog reverse transcriptase inhibitors on cell-mediated immune functionsLaura Enomoto, Peter L Anderson, Shaobing Li, et al.
AIDS Research and Human Retroviruses|April 29, 2021
<i>Letter to the Editor:</i> Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, David V Glidden, Robert M Grant, et al.
Pharmacotherapy|March 24, 2006
Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infectionJennifer J Kiser, Kenneth A Lichtenstein, Peter L Anderson, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Review and management of drug interactions with boceprevir and telaprevirJennifer J Kiser, James R Burton, Peter L Anderson, et al.
Clinical Pharmacology and Therapeutics|April 17, 2002
CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acidPeter L Anderson, Richard C Brundage, Thomas N Kakuda, et al.
Frontiers in Pharmacology|September 28, 2020
Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIVMax von Kleist, J Gerardo García-Lerma, Albert Liu, et al.
Pageof 27